Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-02-18

Clinical Trial Update: Impact of Cilostazol Versus Cilostazol and Selenium Combination on the Healing of Diabetic Foot Ulcer Patients [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 trial comparing cilostazol alone versus cilostazol plus selenium for healing in diabetic foot ulcer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pletal (cilostazol)
  • Selenium supplement (selenium)

Snippet

Sponsor: Ain Shams University | Conditions: Wound Heal | Phase 2, Phase 3 | Status: COMPLETED